Trimi vs Fifty 410

Both sell tirzepatide. Trimi costs $125 a month and Fifty 410 costs $133, a difference of $8 a month or about $96 a year. The other differences matter more than the money if this is your first course.

Trimi is lowest flat price with named pharmacies. Fifty 410 is prepaid blocks with no subscription. They are not aimed at the same person, and the cheaper one is not automatically the right answer — particularly if this is your first course and you expect a slow titration.

What this means for your titration. Trimi holds one price at every dose and Fifty 410 does not — so this gap widens as you titrate toward a therapeutic dose, exactly when you can least afford a surprise.

Side by side

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The differences that affect treatment

2 of these affect how treatment actually goes. The rest are administrative.

What each programme publishes: Trimi

• Compounded tirzepatide advertised at $125/month on the annual plan.
• Names its compounding pharmacies publicly: VialsRx (Texas Board of Pharmacy #35264) and GreenwichRx, with a certificate of analysis available on request.
• Medical oversight via Arora Health, a 50-state network led by Dr. Sean Arora, MD.

Where it wins: The cheapest verified flat rate for compounded tirzepatide in this comparison. Watch for: Both headline prices are annual-plan rates. Confirm the month-to-month figure and the refund terms before prepaying twelve months.

What each programme publishes: Fifty 410

• Compounded tirzepatide starter protocol at $133/month, sold as a $399 three-month block.
• States it is a telehealth platform that does not compound or distribute medication itself, and that preparations come from FDA-registered 503A pharmacies.
• Publishes unusually detailed information on 503A standards, USP 797 sterility and batch testing.

Where it wins: Genuinely no subscription — you buy a block and nothing recurs. Watch for: The $133 is the starter protocol. Moving to the high-dose protocol takes it to $183/month, and both are prepaid three-month commitments.

Strengths of each

Trimi.

• The cheapest verified flat rate for compounded tirzepatide in this comparison.
• Names its pharmacies with a licence number and offers a certificate of analysis — almost nobody else in this market does.
• Price does not move as your dose is adjusted.

Fifty 410.

• Genuinely no subscription — you buy a block and nothing recurs.
• Among the lowest tirzepatide rates verified.
• Unusually detailed public explanation of 503A standards and batch testing.

Trimi scores higher overall at 4.6 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

Which suits you

If this is your first course, weight the two rows about dose pricing above everything else. A programme that keeps the price flat lets you stop climbing when your body says so, and that single freedom does more for whether you are still taking this in month three than $8 a month does.

The verdict

For most people starting out, Trimi at $125 a month is the more defensible choice on arithmetic alone. Fifty 410 earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Trimi and Fifty 410.

How they sit against everyone else